Nuclear localization of 14-3-3epsilon inversely correlates with poor long-term survival of patients with colorectal cancer

Journal of Surgical Oncology

Volumn 106, Issue 3, 2012, Pages 224-231

  Wang, Hui ^a   Huang, Haoran ^b   Li, Weidong ^a   Jin, Xuejun ^a   Zeng, Jian ^a   Liu, Yawei ^b   Gu, Ye ^b   Sun, Xuegang ^b   Wen, Ge ^b   Ding, Yanqing ^b   Zhao, Liang ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

14 3 3epsilon; colorectal cancer; metastasis; poor prognosis; tumor progression

Indexed keywords

14 3 3 EPSILON; BIOLOGICAL MARKER; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL NUCLEUS; COLORECTAL CANCER; CYTOSOL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONG TERM SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

14-3-3 PROTEINS; BLOTTING, WESTERN; CARCINOEMBRYONIC ANTIGEN; CELL NUCLEUS; COLORECTAL NEOPLASMS; CYTOSOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS;

EID: 84864704771     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22152     Document Type: Article

References (33)

1. Fu H, Subramanian RR, Masters SC,: 14-3-3 proteins: Structure, function, and regulation. Annu Rev Pharmacol Toxicol 2000; 40: 617-647.
2. van Hemert MJ, Steensma HY, van Heusden GP,: 14-3-3 proteins: Key regulators of cell division, signalling and apoptosis. Bioessays 2001; 23: 936-946.
3. Wilker E, Yaffe MB,: 14-3-3 proteinsA focus on cancer and human disease. J Mol Cell Cardiol 2004; 37: 633-642.
4. Muslin AJ, Tanner JW, Allen PM, et al.: Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 1996; 84: 889-897.
5. Yaffe MB, Rittinger K, Volinia S, et al.: The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 1997; 91: 961-971.
6. Han DC, Rodriguez LG, Guan JL,: Identification of a novel interaction between integrin beta1 and 14-3-3beta. Oncogene 2001; 20: 346-357.
7. Fanger GR, Widmann C, Porter AC, et al.: 14-3-3 proteins interact with specific MEK kinases. J Biol Chem 1998; 273: 3476-3483.
8. Tzivion G, Luo Z, Avruch J,: A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature 1998; 394: 88-92.
9. Bonnefoy-Berard N, Liu YC, von Willebrand M, et al.: Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells. Proc Natl Acad Sci USA 1995; 92: 10142-10146.
10. Zha J, Harada H, Yang E, et al.: Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996; 87: 619-628.
11. Zhang L, Chen J,: Fu H: Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc Natl Acad Sci USA 1999; 96: 8511-8515.
12. Hermeking H, Lengauer C, Polyak K, et al.: 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1997; 1: 3-11.
13. Laronga C, Yang HY, Neal C, et al.: Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 2000; 275: 23106-23112.
14. Lopez-Girona A, Furnari B, Mondesert O, et al.: Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature 1999; 397: 172-175.
15. Macdonald N, Welburn JP, Noble ME, et al.: Molecular basis for the recognition of phosphorylated and phosphoacetylated histone h3 by 14-3-3. Mol Cell 2005; 20: 199-211.
16. Walter W, Clynes D, Tang Y, et al.: 14-3-3 interaction with histone H3 involves a dual modification pattern of phosphoacetylation. Mol Cell Biol 2008; 28: 2840-2849.
17. Winter S, Simboeck E, Fischle W, et al.: 14-3-3 proteins recognize a histone code at histone H3 and are required for transcriptional activation. EMBO J 2008; 27: 88-99.
18. Che XH, Chen H, Xu ZM, et al.: 14-3-3epsilon contributes to tumour suppression in laryngeal carcinoma by affecting apoptosis and invasion. BMC Cancer 2010; 10: 306.
19. Hou Z, Peng H, White DE, et al.: 14-3-3 binding sites in the snail protein are essential for snail-mediated transcriptional repression and epithelial-mesenchymal differentiation. Cancer Res 2010; 70: 4385-4393.
20. Liang S, Xu Y, Shen G, et al.: Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly increasing renal cell proliferation. Electrophoresis 2009; 30: 4152-4162.
21. Liang X, Butterworth MB, Peters KW, et al.: An obligatory heterodimer of 14-3-3beta and 14-3-3epsilon is required for aldosterone regulation of the epithelial sodium channel. J Biol Chem 2008; 283: 27418-27425.
22. 2+ pump. Cell Calcium 2008; 43: 550-561.
23. Mizuno E, Kitamura N, Komada M,: 14-3-3-dependent inhibition of the deubiquitinating activity of UBPY and its cancellation in the M phase. Exp Cell Res 2007; 313: 3624-3634.
24. Konishi H, Nakagawa T, Harano T, et al.: Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3epsilon at 17p13.3 in small cell lung cancers. Cancer Res 2002; 62: 271-276.
25. Cvekl A, Jr., Zavadil J, Birshtein BK, et al.: Analysis of transcripts from 17p13.3 in medulloblastoma suggests ROX/MNT as a potential tumour suppressor gene. Eur J Cancer 2004; 40: 2525-2532.
26. Lukashova-v Zangen I, Kneitz S, Monoranu CM, et al.: Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival. Acta Neuropathol 2007; 113: 325-337.
27. Tak H, Jang E, Kim SB, et al.: 14-3-3epsilon inhibits MK5-mediated cell migration by disrupting F-actin polymerization. Cell Signal 2007; 19: 2379-2387.
28. Zhao L, Wang H, Li J, et al.: Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer. J Proteome Res 2008; 7: 3994-4003.
29. Coppola D, Szabo M, Boulware D, et al.: Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 2004; 10: 184-190.
30. Tan PH, Bay BH, Yip G, et al.: Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death. Mod Pathol 2005; 18: 374-381.
31. Zhao L, Liu L, Wang S, et al.: Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins. J Cancer Res Clin Oncol 2007; 133: 771-782.
32. Ramagli LS,: Quantifying protein in 2-D PAGE solubilization buffers. Methods Mol Biol 1999; 112: 99-103.
33. Li C, Iida M, Dunn EF, et al.: Nuclear EGFR contributes to acquired resistance to cetuximab. Oncogene 2009; 28: 3801-3813.